Research Staff

Dr Jia ZHAO
Research Assistant Professor
School of Chinese Medicine
The University of Hong Kong
ACADEMIC QUALIFICATIONS
July 2011-June 2015 PhD in Chinese Medicine, School of Chinese Medicine, the University of Hong Kong, Hong Kong
Sept 2006-June 2009 M.Sc. in Integrative Medicine of Western and Chinese Traditional Medicine, Huazhong University of Science and Technology, Wuhan, China
Sept 2001-June 2006 B.Sc. in Traditional Chinese Medicine, Hubei University of Traditional Chinese Medicine, Wuhan, China
AREAS OF EXPERTISE
2014 Hong Kong Certificate of Registration for Chinese Medicine Practitioner, Hong Kong Practising Certificate for Registered Chinese Medicine Practitioner, Member of Hong Kong Association of Traditional Chinese Medicine
2024 Member of Hong Kong Registered Chinese Medicine Practitioners Association
WORKING EXPERIENCE
Jan 2023-Present Research Assistant Professor, School of Chinese Medicine, The University of Hong Kong, Hong Kong
Jan 2021 - Dec 2022 Assistant Lecturer, School of Chinese Medicine, The University of Hong Kong, Hong Kong
Jan 2016 - Dec 2020 Post-doctoral fellow in Chinese Medicine, School of Chinese Medicine, University of Hong Kong, Hong Kong
Feb 2017 - Present Honorary Research Associate, Department of Chinese Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China
Sep 2015 - Jan 2016 Research assistant in Chinese Medicine, School of Chinese Medicine, University of Hong Kong, Hong Kong
RESEARCH INTEREST AND ACHIEVEMENT

RESEARCH FIELDS


The therapeutic effects and the underlying mechanism of Chinese medicines in the neurodegenerative disease, depression and pain.

RESEARCH GRANTS

EXTERNAL RESEARCH GRANTS


  1. General Research Fund 17108725, Potential role of RagA-Adora2A-lncRNA TCONS_00004755 axis in depression: implication for the antidepressant mechanism of Chinese medicine isoflavone puerarin. PI. HKD 1,375,300. 01/09/2025-31/08/2028, On-going.
  2. Health and Medical Research Fund (HMRF) 17181231, RNA-Seq transcriptome profiling of Rraga-knock-in mouse brains for the mechanisms underlying the anti-depressive activity of Chinese medicine puerarin. PI. HKD 100,000. 01/07/2020-30/06/2023, Completed.
  3. 深圳市科技計劃基礎研究自由探索項目, 應用轉錄組學研究中藥葛根素抗抑鬱和止痛的作用及機制, PI. RMB 105,000, 19/03/2019-31/03/2022, Completed.
  4. 高水平醫院建設科研培育計劃重點項目,基於Rraga轉基因鼠的轉錄組學研究中藥葛根活性成分葛根素抗抑鬱的分子機制, PI. RMB 400,000, 01/07/2019-30/06/2022, Completed.
  5. Nature and Science Foundation China (NSFC) 81703726, Unexpected dual antidepressant and analgesic activities of Chinese medicine puerarin and the underlying mechanism. PI. RMB 200,000, 01/01/2018-31/12/2020, Completed.
  6. Health and Medical Research Fund (HMRF) 15161731, Transcriptomic Profiling of the Gene Networks Reveals the Roles of BDNF and RragA in the Anti-Depressive and Analgesic Activities of Chinese Medicine Puerarin. PI. HKD 100,000. 01/04/2018-31/03/2020, Completed. 
  7. National Natural Science Fundation of China (NSFC), 2018-2020, 21778046, Arachidonic acid metabolite (15-keto-PGF2α) regulates macrophage M1/M2 polarization against myocardial ischemia reperfusion injury via covalent conjugation with glycolytic enzyme PKM2. Co-applicant. RMB¥650,000, 01/01/2018-31/12/2021, Completed.
  8. 高水平醫院建設科研培育計劃青年項目HKUSZH201901011, 基于人工智能整合医学大数据构建胎儿生长异常风险评估工具和辅助评估模型研究, Co-I. RMB 150,000, 01/07/2019-30/06/2022, Completed.
  9. Midstream Research Programme for Universities (MRP) (2018): CCK-B receptor antagonists for the treatment of depression especially chronic pain comorbid depression of elderly. Team member. HK$ 5,000,000, 01/07/2019-30/06/2022, Completed.
  10. Nature and Science Foundation China (NSFC) 81202510, Unexpected anti-Parkinson's neuroprotective and its molecular targets of Sunitinib, a clinical used anti-cancer drug. Co-applicant. HKD 274,174, 01/09/2013-01/09/2015, Completed. 

NTERNAL RESEARCH GRANTS


  1. Seed Fund for Basic Research for New Staff 2201101504, RagA overexpression may cause depressive-like behaviors in mice via activating ADORA2A/p70S6K signaling pathway. PI. HKD 150,000. 30/06/2023-31/12/2025, On-going.
  2. Research Assessment Exercise (RAE) 2026 Preparation 102010294. PI. HKD 100,000. 11/07/2024-31/12/2025, On-going.
  3. Seed Fund for Basic Research for Resubmission of GRF/ECS Proposals 2409100350 PI. HKD 54,750. 01/07/2024-30/11/2024, Completed.
AWARDS

Mentor: Zhao Jia, 2024 Belt and Road International Undergraduate Forum for Basic Innovative Experiment Design in Medical Sciences, bronze award, August 22-25, 2024, Guangzhou, China.

TEACHING SUBJECTS

Zhao Jia taught the lectures in the following courses:
BCHM1601 Foundation Theories of Chinese Medicine
BCHM2607 Medical Ethics and Professionalism in Chinese Medicine (Course Co-ordinator)
BCHM1602 Diagnostics of Chinese Medicine
BCHM5607 Pharmacology of Chinese Medicine
BCHM6601 Clinical Clerkship
BPHM4152 Chinese Medicine for Pharmacy Students
BPHM2143 Pharmacy in Body System Series: Cardiovascular & Renal

SELECTED PUBLICATIONS

SELECTED PUBLICATIONS (*, Correspondence; # co first author)


1) First author and #co first author


  1. Jia Zhao1,2,#, Yilu Sun1,#, Yibin Feng1*, Jianhui Rong1*. Brain specific RagA overexpression triggers depressive-like behaviors in mice via activating ADORA2A signaling pathway. Advanced Science. 2024 Dec;11(45):e2404188. doi: 10.1002/advs.202404188. Epub 2024 Oct 7. (IF: 14.3)
  2. Zhao J#, Luo D#, Zhang Z, Fan N, Wang Y, Nie H, Rong J. Celastrol-loaded PEG-PCL nanomicelles ameliorate inflammation, lipid accumulation, insulin resistance and gastrointestinal injury in diet-induced obese mice. J Control Release. 2019; 310, 188-197. doi: 10.1016/j.jconrel.2019.08.026. (IF: 10.5)
  3. Zhao J, Lao L, Cui W, Rong J. Potential link between the RagA-mTOR-p70S6K axis and depressive-behaviors during bacterial liposaccharide challenge. J Neuroinflammation. 2019 Nov 11;16(1):211. (IF: 9.3)
  4. K. Y. Tong#, J. Zhao#, C. Tse, P. Wan, J. Rong and H. Y. Au-Yeung. Selective Catecholamine Detection in Living Cells by a Copper-based Oxidative Reactivity. Chem. Sci. 2019; 10 (37), 8519-8526. DOI: 10.1039/C9SC03338F. (IF: 7.6)
  5. Jia Zhao, Yizhen Jia, Wei Zhao, Huixin Chen, Xiuying Zhang, Fung Yin Ngo, Dan Luo, Youqiang Song, Lixing Lao, and Jianhui Rong. Botanical Drug Puerarin Ameliorates Liposaccharide-Induced Depressive Behaviors in Mice via Inhibiting RagA/mTOR/p70S6K Pathways. Oxid Med Cell Longev. 2021 Oct 18;2021:7716201. doi: 10.1155/2021/7716201. eCollection 2021. (Mock RAE 2023: 3 star)
  6. Zhao Y#, Zhao J#, Zhang X, Cheng Y, Luo D, Lee SM, Lao L, Rong J. Botanical Drug Puerarin Promotes Neuronal Survival and Neurite Outgrowth against MPTP/MPP+-Induced Toxicity via Progesterone Receptor Signaling. Oxid Med Cell Longev. 2020 Oct 17;2020:7635291. doi: 10.1155/2020/7635291. eCollection 2020. (Mock RAE 2023: 3 star)
  7. Jia Zhao*, Mengxia Zhu, Mukesh Kumar, Fung Yin Ngo, Yinghui Li, Lixing Lao, Jianhui Rong. A pharmacological appraisal of neuroprotective and neurorestorative flavonoids against neurodegenerative diseases. CNS Neurol Disord Drug Targets. 2019;18(2):103-114. doi: 10.2174/1871527317666181105093834. (review, IF: 2.7)
  8. Jia Zhao, Dan Luo, Zhaohui Liang, Lixing Lao, Jianhui Rong. Plant Natural Product Puerarin Ameliorates Depressive Behaviors and Chronic Pain in Mice with Spared Nerve Injury (SNI). Molecular Neurobiology, 2017 May;54(4):2801-2812. doi: 10.1007/s12035-016-9870-x.(IF: 4.6)
  9. Jia Zhao, Yuanyuan Cheng, Chuanbin Yang, Sam Lau, Lixing Lao, Bo Shuai, Jing Cai, Jianhui Rong. Botanical drug puerarin attenuates 6-hydroxydopamine (6-OHDA)- induced neurotoxicity via upregulating mitochondrial enzyme arginase-2. Molecular Neurobiology, 2016 May;53(4):2200-11. doi: 10.1007/s12035-015-9195-1. (IF: 4.6)
  10. Jia Zhao, Yuanyuan Cheng, Wen Fan, Chuanbin Yang, Shuifen Ye, Wei Cui, Wei Wei, Lixing Lao, Jing Cai, Yifan Han, Jianhui Rong. Botanical drug puerarin coordinates with nerve growth factor (NGF) in the regulation of neuronal survival and neuritogenesis via activating ERK1/2 and PI3K/Akt signaling pathways in the neurite extension process. CNS Neuroscience & Therapeutics. 2015 Jan;21(1):61-70. (IF: 4.8)
  11. Jia Zhao*#, Di Wang*#, Wei Cui*#, Hansen Chen*#. Editorial: Natural products in the treatment of neurological diseases: identification of novel active compounds and therapeutic targets. Front. Pharmacol., 22 September 2023 Sec. Neuropharmacology Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1294625. (IF: 4.4)
  12. Yilu Sun#, Jia Zhao#, Yizhu Lu, Fung Yin Ngo, Bo Shuai, Zhang-Jin Zhang, Yibin Feng* and Jianhui Rong*. In Silico Prediction of Quercetin Analogs for Targeting Death-Associated Protein Kinase 1 (DAPK1) Against Alzheimer’s Disease. Current Neuropharmacology. 2024 May 15. doi: 10.2174/1570159X22666240515090434. (review, IF: 4.8)

  13. 2) * Correspondence


  14. Yilu Sun, Jia Zhao*, Jianhui Rong*. Tyrosinase inhibition by natural stilbenoid glycosides: Critical role of the vinyl moiety in piceid for melanogenesis suppression. Arch Biochem Biophys. 2025 Jun;768:110405. doi: 10.1016/j.abb.2025.110405. Epub 2025 Mar 28. (IF: 3.8)
  15. Yilu Sun,Jian Fu, Jiayin Yang, Jia Zhao*, Jianhui Rong*. Generation of a RRAGA knockout human iPSC line GIBHi002-A-5 using CRISPR/Cas9 technology. Stem Cell Research. 2022 August; 63, 102859. (IF: 0.8)
  16. Yilu Sun, Jia Zhao*, Jianhui Rong*. Dissecting the molecular mechanisms underlying the antidepressant activities of herbal medicines through the comprehensive review of the recent literatures. Frontiers in Psychiatry. 2022 Dec 22;13:1054726. doi: 10.3389/fpsyt.2022.1054726. (review, IF: 3.2)
  17. Yilu Sun, Qilei Chen, Wei Cui, Hubiao Chen, Jia Zhao*, and Jianhui Rong*. Six-compound combo remedy ameliorates corticosterone-induced depressive behaviors in mice via targeting HTR1A signaling. Journal of Leukocyte Biology. 2024 Jul 31:qiae167. doi: 10.1093/jleuko/qiae167. Online ahead of print. (IF: 3.6)
  18. Chi Lui Chan#, Yilu Sun#, Xiaowen Mao, Hansen Chen, Jia Zhao*, Jianhui Rong*. Druggability, molecular targets and nanocarrier delivery of natural triterpenoid celastrol against chronic inflammatory diseases. Acta Materia Medica. Acta Materia Medica 2024, 3(4): 383-404. DOI: 10.15212/AMM-2024-0044. (review)

  19. 3) Other authors


  20. Lingling Zheng, Weiyao Liao, Shan Luo, Bingyu Li, Di Liu, Qingping Yun, Ziyi Zhao, Jia Zhao, Jianhui Rong, Zhiguo Gong, Jinling Tang, Feng Sha*. Association between Alcohol Consumption and Incidence of Dementia in Current Drinkers: Linear and Non-linear Mendelian Randomization Analysis. eClinicalMedicine. 2024;76: 102810. DOI: 10.1016/j.eclinm.2024.102810. (IF: 9.6)
  21. Qin Z, Shi DD, Li W, Cheng D, Zhang YD, Zhang S, Tsoi B, Zhao J, Wang Z, Zhang ZJ. Berberine ameliorates depression-like behaviors in mice via inhibiting NLRP3 inflammasome mediated neuroinflammation and preventing neuroplasticity disruption. J Neuroinflammation. 2023 Mar 1;20(1):54. doi: 10.1186/s12974-023-02744-7. (IF: 9.3)
  22. Zhang X, Chen Q, Zhao J, Zhao W, Fan N, Wang Y, Chen H and Rong J (2023), A four compound remedy AGILe protected H9c2 cardiomyocytes against oxygen glucose deprivation via targeting the TNFα/NF-κB pathway: Implications for the therapy of myocardial infarction. Front. Pharmacol. 14:1050970. doi: 10.3389/fphar.2023.1050970. (IF: 4.4)
  23. Wei Zhao#, Xiuying Zhang#, Jia Zhao, Ni Fan, Jianhui Rong. SUMOylation of Nuclear γ-Actin by SUMO2 supports DNA Damage Repair against Myocardial Ischemia-Reperfusion Injury. Int J Biol Sci 2022; 18(11):4595-4609. doi:10.7150/ijbs.74407. (IF: 8.2)
  24. Ni Fan, Xiuying Zhang, Wei Zhao, Jia Zhao, Dan Luo, Yilu Sun, Ding Li, Chenliang Zhao, Yu Wang, Hongjie Zhang, Jianhui Rong*. Covalent Inhibition of Pyruvate Kinase M2 Reprograms Metabolic and Inflammatory Pathways in Hepatic Macrophages against Non-alcoholic Fatty Liver Disease. International Journal of Biological Sciences 2022; 18(14):5260-5275. DOI: 10.7150/ijbs.73890. (IF: 8.2)
  25. Fan N, Zhao J, Zhao W, Zhang X, Song Q, Shen Y, Shum HC, Wang Y, Rong J. Celastrol-loaded lactosylated albumin nanoparticles attenuate hepatic steatosis in non-alcoholic fatty liver disease. J Control Release. 2022 May 4;347:44-54. doi: 10.1016/j.jconrel.2022.04.034. Online ahead of print. (IF: 10.5)
  26. Luo D#, Fan N#, Zhang X, Ngo FY, Zhao J, Zhao W, Huang M, Li D, Wang Y, Rong J. Covalent inhibition of endoplasmic reticulum chaperone GRP78 disconnects the transduction of ER stress signals to inflammation and lipid accumulation in diet-induced obese mice. Elife. 2022 Feb 9;11:e72182. doi: 10.7554/eLife.72182. (IF: 6.4)
  27. Fan N, Zhao J, Zhao W, Shen Y, Song Q, Shum HC, Wang Y, Rong J. Biodegradable celastrol-loaded albumin nanoparticles ameliorate inflammation and lipid accumulation in diet-induced obese mice. Biomater Sci. 2022 Feb 15;10(4):984-996. doi: 10.1039/d1bm01637g. (IF: 5.8)
  28. Lu J, Hu D, Ma C, Xu X, Shen L, Rong J, Zhao J and Shuai B (2022). Modified Qing’ e Pills exerts anti-osteoporosis effects and prevents bone loss by enhancing type H blood vessel formation. Front. Endocrinol. 13:998971. doi: 10.3389/fendo.2022.998971. (IF: 3.9)
  29. Wei Zhao, Jia Zhao, Xiuying Zhang, Ni Fan, Jianhui Rong. Upregulation of Small Ubiquitin-Like Modifier 2 and Protein SUMOylation as a Cardioprotective Mechanism Against Myocardial Ischemia-Reperfusion Injury. Front Pharmacol. 2021 Sep 13;12:731980. doi: 10.3389/fphar.2021.731980. eCollection 2021. (IF: 4.4)
  30. Zhao W, Zhao J, Rong J. Pharmacological Modulation of Cardiac Remodeling after Myocardial Infarction. Oxid Med Cell Longev. 2020 Dec 30;2020:8815349. doi: 10.1155/2020/8815349. eCollection 2020. (review)
  31. Fung Yin Ngo, Weiwei Wang, Qilei Chen, Jia Zhao, Hubiao Chen, Jin-Ming Gao, Jianhui Rong. Network Pharmacology Analysis and Molecular Characterization of the Herbal Medicine Formulation Qi-Fu-Yin for the Inhibition of the Neuroinflammatory Biomarker iNOS in Microglial BV-2 Cells: Implication for the Treatment of Alzheimer's Disease. Oxid Med Cell Longev. 2020 Aug 31;2020:5780703. doi: 10.1155/2020/5780703. eCollection 2020.
  32. Zhong Zhang, Xin Ma, Bowei Li, Jia Zhao, Ji Qi, Guoying Hao, Rong Jianhui*, Xingbin Yang*. Fluorescence Detection of 2,4-dichlorophenoxyacetic Acid by Ratiometric Fluorescence Imaging on Paper-Based Microfluidic Chips. Analyst. 2020 Feb 3;145(3):963-974. doi: 10.1039/c9an01798d. (IF: 3.6)
  33. Luo D, Guo Y, Cheng Y, Zhao J, Wang Y, Rong J. Natural product celastrol suppressed macrophage M1 polarization against inflammation in diet-induced obese mice via regulating Nrf2/HO-1, MAP kinase and NF-κB pathways. Aging (Albany NY). 2017 Oct 16;9(10):2069-2082. (IF: 3.9)
  34.  Luo D, Zhao J, Cheng Y, Lee SM, Rong J, N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson’s Disease and in MPP+-Induced Neurons via Promoting the Conversion of proNGF to NGF, Mol Neurobiol, 2018 Mar;55(3):2258-2267. doi: 10.1007/s12035-017-0486-6. (IF: 4.6)
  35. Chuanbin Yang, Jia Zhao, Yuanyuan Cheng, X Chris Le, Jianhui Rong, N-Propargyl caffeate amide (PACA) potentiates nerve growth factor (NGF)-induced neurite outgrowth and attenuates 6-hydroxydopamine (6-OHDA)-induced toxicity via activating the Nrf2/HO-1 pathway, ACS Chem Neurosci. 2015 Sep 16;6(9):1560-9. doi: 10.1021/acschemneuro.5b00115. Epub 2015 Jul 16. (IF: 4.1)
  36. Yuanyuan Cheng, Jia Zhao, Hung Fat Tse, X Chris Le, Jianhui Rong, Plant natural products calycosin and gallic acid synergistically attenuate neutrophil infiltration and subsequent injury in isoproterenol-induced myocardial infarction: a possible role for leukotriene B4-12-hydroxydehydrogenase? Oxidative Medicine and Cellular Longevity, 2015;2015:434052.
  37. Hongyi Qi, Jia Zhao, Yifan Han, Allan S.Y. Lau, Jianhui Rong. Z-ligustilide potentiates the cytotoxicity of dopamine in rat dopaminergic PC12 cells. Neurotox Res (2012) 22:345–354. (IF: 2.9)
  38. Chuanbin Yang, Jia Zhao, Weijing Pei, Xiaohui Zheng, Jianhui Rong. Biochemical mechanisms of bornyl caffeate induced cytotoxicity in rat pheochromocytoma PC12 cells. Chemico-Biological Interactions, 2014,219:133-142. (IF: 4.7)
  39. Chuanbin Yang, Jia Zhao, Yuanyuan Cheng, Xuechen Li, Jianhui Rong. Bioactivity- guided fractionation identifies amygdalin as a potent neurotrophic agent from herbal medicine Semen Persicae extract. BioMed Research International, 2014;2014:306857. (IF: 2.6)
  40. Dan Luo, Jia Zhao, Jianhui Rong. Plant-derived triterpene celastrol ameliorates oxygen glucose deprivation-induced disruption of endothelial barrier assembly via inducing tight junction proteins. Phytomedicine. 2016 Dec;23(13):1621-1628. (IF: 6.7)
  41. Yuanyuan Cheng, Chuanbin Yang, Jia Zhao, Hung Fat Tse, Jianhui Rong. Proteomic identification of calcium-binding chaperone calreticulin as a potential mediator for the neuroprotective and neuritogenic activities of fruit-derived glycoside amygdalin. Journal of Nutritional Biochemistry. 2015Feb;26(2):146-54. (IF: 4.8)
  42. Chuanbin Yang, Weijing Pei, Jia Zhao, Yuanyuan Cheng, Xiaohui Zheng, Jianhui Rong, Bornyl caffeate induces apoptosis in human breast cancer MCF-7 cells via the ROS- and JNK-mediated pathway. Acta Pharmacologica Sinica, 2014,35(1):113-123. (IF: 6.9)
  43. Bo Shuai, Yanping Yang, Lin Shen, Rui Zhu, Xiaojuan Xu, Jia Zhao, Jianhui Rong. Local renin-angiotensin system is associated with bone mineral density of glucocorticoid- induced osteoporosis patients. Osteoporos Int (2015) 26:1063–1071. (IF: 4.2)
  44. Yang, Chuanbin, Cheng, Yuanyuan, Zhao, Jia, Rong, Jianhui. Releasing Nrf2 to promote neurite outgrowth. Neural Regeneration Research, 2015-12, 10(12): 1934-1935. (review, IF: 5.9)
  45. Yu-Bo Zhang, Kar-Ho Lam, Li-Feng Chen, Hei Wan, Guo-Cai Wang, Kai-Fai Lee, Chun-Wang Yip, Kwun-Hung Liu, Pak-Heng Leung, Hai-Yong Chan, Yi-Gang Shi, Jia Zhao, Li-Xing Lao, Yao-Lan Li, Yan-Bo Zhang, Wei Meng. Chemical constituents from the thorns of Gleditsia sinensis and their cytotoxic activities. J Asian Nat Prod Res. 2020 Apr 15;1-9. doi: 10.1080/10286020.2020.1731799. Online ahead of print. (IF: 1.3)
  46. Lu Xia, Chuangen Li, Jia Zhao, Quancai Sun, Xiaowen Mao*. Rebalancing immune homeostasis in combating disease: The impact of medicine food homology plants and gut microbiome. Phytomedicine. 2025 Jan:136:156150. doi: 10.1016/j.phymed.2024.156150. (IF: 6.7)
  47. Leanne Lee Leung, Jing Xie, Ya-Cun Chen, Kar-Ho Lam, Hei Wan, Su-Lan Yu, Tzi-Bun Ng, George Pak-Heng Leung, Jin Yu, Ren-Min Yao, Shu-Jia Sun, Sydney Chi-Wai Tang, Hai-Yong Chen, Jia Zhao, Zhang-Jin Zhang, Calvin Kai-Fai Lee, Kalin Yan-Bo Zhang, Li-Xing Lao, Yun Feng, Xiang Lin*, Wei Meng*. Pharmacological efficacy of the traditional Chinese medicinal formula Kun-Tai-1A in the treatment of letrozole-induced polycystic ovary syndrome. Traditional Medicine Research. 2022;7(3):22. DOI:10.53388/TMR20220225265. (In Chinese).
  48. Yuanyuan Cheng, Jia Zhao, Jianhui Rong, Chapter 9, Proteomic response fingerprinting (ProReF) for rapid identification of protein targets for Chinese medicine, in Evidence-based Research Methods for Chinese Medicine, Siu-wai Leung, Hao Hu (Eds.), Pages 131-145 (2016), SpringerLink.
  49. Chuanbin Yang, Yuanyuan Cheng, Jia Zhao, Jianhui Rong. Flavonones potential use as pharmacoligcal agents. International Journal of Traditional Chinese Medicine, 2014,36(4):370-375. (In Chinese).
  50. Yuanyuan Cheng, Chuanbin Yang, Jia Zhao, Jianhui Rong. Purification of Z- ligustilide by AgNO3-Impregnated Silica Gel. Chinese Journal of Modern Applied Pharmacy, 2014,31(5):552-555 (In Chinese).
  51. Bo Shuai, Lin Shen, Yan-ping Yang, Jing Xie, Pi-qi Zhou, Heng Li, Xiang-fei Guo, Jia Zhao, Jia-lin Wu. Effects of Chinese kidney-tonifying drugs on bone mineral density (BMD), biomechanics, 25-hydroxy vitamin D3 and 1,25-dihydroxy vitamin D3 of ovariectomized osteoporosis rats. Zhongguo Gu Shang. 2008 Nov;21(11):850-3. (In Chinese).
  52. Hei Wan, Kar-Ho Lam, Hei-Yi Man, Kwun-Hung Liu, Ming-Ngai Lau, Chun-Wang Yip, Chun-Hei Cheung, Lik-Hang Wong, Kai-Fai Lee, Kalin Yan-Bo Zhang, Jia Zhao, Hai-Yong Chen, Jin Yu, Zhang-Jin Zhang, Li-Xing Lao#, Wei Meng#. New Progress in the Research of TCM Clinical Formula in the Treatment of Polycystic Ovary Syndrome. Traditional Chinese Medicine. Vol. 08 No. 01 (2019), ID: 28504. 7 pages. (In Chinese).
  53. Chun-Wang Yip, Hei Wan, Kar-Ho Lam, Chun-Hei Cheung, Kwun-Hung Liu, Hei-Yi Man, Ming-Ngai Lau, Lik-Hang Wong, Nan-Sun Zhu, Kai-Fai Lee, Kalin Yan-Bo Zhang, Jun Shi, Jia Zhao, Hai-Yong Chen, Zhang-Jin Zhang, Li-Xing Lao, Wei Meng. Specialist Prescription of Chinese Medicine for Treatment of EMT Dysmenorrhea and Related Experimental Research Analysis. Traditional Chinese Medicine. 2019, 8(4): 254-261. (In Chinese).
  54. Qing Ye, Nansun Zhu, Jin Yu, Li Dong, Fang Pan, Youzhou Yang, Jia Zhao, Wei Meng*. A Systematic Review and Meta-Analysis of the Efficacy of Traditional Chinese Medicine Combined with Western Medicine against Western Medicine Alone in Improving Endometrium Receptivity in Infertility Patients. Traditional Chinese Medicine, 2024, 13(7), 1674-1696. (In Chinese).
  55. Wanyi Au, Jin Yu, Nansun Zhu, Li Dong, Fang Pan, Youzhou Yang, Jia Zhao, Wei Meng*. The Relationship between Assisted Reproductive Technology IVF-ET and the Incidence of Gynecological Ovarian Tumors and the Position and Significance of the Intervention of Traditional Chinese Medicine. Traditional Chinese Medicine, 2023, 12(9), 2679-2692. (In Chinese).
  56. Kar Fung Tam, Xiang Lin, Haiyong Chen, Jia Zhao, Li Dong, Nansun Zhu, Wei Meng. Research and Application of “Chong-Ren”Theory in Zhu’s TCM Gynaecology. Traditional Chinese Medicine, 2022, 11(5): 906-913. DOI: 10.12677/tcm.2022.115131. (In Chinese).
  57. Qing Ye, Jia Zhao, Nansun Zhu, Jin Yu, Li Dong, Fang Pan, Youzhou Yang, Jianhui Rong, Wei Meng*. Discussion of the Rule and Characteristics of Chinese Medicine in Improving Endometrial Receptivity on the Basis of Evidence-Based Medicine Meta-Analysis. Traditional Chinese Medicine, 2025, 14(1), 422-440. (In Chinese).
  58. 羅其文, 趙佳,榮建輝,施冬雲*. 中藥組方通過黃酮多酚類抗氧化物質多靶點調節氧化還原狀態阻遏病毒感染與炎性反應. 天津中醫藥 2025 (accepted)